Related Experiment Videos
The critical relationship of antibiotic dose and bacterial contamination in experimental infection
M S Citak1, J I Cué, J C Peyton
1Department of Surgery, University of Louisville School of Medicine, Kentucky.
Abstract:
Even though the usefulness of prophylactic antimicrobial administration for potentially contaminated operations is widely accepted, infection continues to occur in a finite number of cases. This study examined whether potential infection due to an increasing bacterial inoculum can be prevented or controlled by increasing antimicrobial doses. In an initial set of experiments, Sprague-Dawley rats were given various doses of cefazolin (15, 30, 60, 120 mg/kg) intraperitoneally, then serum and tissue levels were quantified. Serum and tissue drug concentrations correlated with the dose given. In another set of experiments, rats were given doses of either 0, 30 (standard dose), 60, or 120 mg/kg of cefazolin 30 min prior to subcutaneous inoculation of various doses of Staphylococcus aureus. After 6 days, inoculum sites were examined for abscess formation and size. At low levels of contamination, increasing in antibiotic dose to 30, 60, and 120 mg/kg, abscess formation was eliminated at 50, 80, and 92% of inoculum sites, respectively. At moderate levels of contamination, abscesses formed at all inoculum sites, but abscess size was significantly smaller as the dose increased. When a high inoculum of S. aureus was given, large doses of antibiotics provided no additional benefit. These data suggest that the risk of infection in this model of experimental infection is significantly related to the size of the bacterial inoculum. Increasing the dose of an effective antimicrobial increases drug concentration at the site of contamination and reduces the risk of infection. Administration of higher doses of prophylactic antimicrobials may be more effective when larger amounts of bacterial contamination are anticipated.
Insights
Increasing cefazolin doses reduced infection risk in rats with low bacterial contamination. However, high bacterial loads overwhelmed even higher antibiotic doses, indicating inoculum size is critical for infection prevention.
Area of Science:
- Surgical infection prevention
- Pharmacokinetics and pharmacodynamics
- Experimental microbiology
Background:
- Prophylactic antimicrobials are standard for potentially contaminated surgeries, but infections still occur.
- The impact of increasing bacterial inoculum size on infection risk and antimicrobial efficacy is not fully understood.
Purpose of the Study:
- To investigate if increasing antimicrobial doses can prevent or control infections caused by increasing bacterial inoculum.
- To determine the relationship between bacterial inoculum size, antibiotic dose, and infection outcomes.
Main Methods:
- Sprague-Dawley rats received varying doses of cefazolin (15-120 mg/kg) to assess serum and tissue drug levels.
- Rats were inoculated with Staphylococcus aureus at different doses and received cefazolin (0, 30, 60, 120 mg/kg) pre-inoculation.
- Abscess formation and size were evaluated 6 days post-inoculation.
Main Results:
- Serum and tissue cefazolin concentrations correlated with administered doses.
- Higher cefazolin doses significantly reduced abscess formation at low bacterial contamination levels (elimination at 50-92%).
- At moderate contamination, higher doses reduced abscess size, but high inoculum levels negated antibiotic benefits.
Conclusions:
- Infection risk is strongly linked to bacterial inoculum size in this experimental model.
- Increasing cefazolin dose enhances drug concentration at the contamination site, reducing infection risk.
- Higher prophylactic antimicrobial doses may be more beneficial when greater bacterial contamination is anticipated.